Venture Certified
| 혁신성장유형 | 2023-09-07 ~ 2026-09-06 | 20230907030004 | 2023-09-07 |
Revenue CAGR +96.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 221.4B | 120.0B | 57.4B |
| Operating Profit | 11.5B | 5.8B | 2.8B |
| Net Profit | 11.2B | 5.4B | 2.3B |
| Total Assets | 88.0B | 44.6B | 30.6B |
| Total Liabilities | 69.1B | 35.2B | 28.3B |
| Total Equity | 18.9B | 9.3B | 2.3B |
▲ 149.6%
▲ 168.2%
▲ 7.6%
▼ 55.1%
▼ 24.7%
| Name | Position | Role |
|---|---|---|
| 이명교 | 대표이사 | 대표 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 경피적으로 전력 공급되는 MR-Conditional 의료용 임플란트 인플레이터 시스템 | 엠에이치엔 바이오테크 엘엘씨 | 1020207034563 | 2019-05-01 | 공개 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 서초구",
"ceo_name": "이명교",
"certificate": [
{
"cert_number": "20230907030004",
"changes": "",
"disclosure_date": "2023-09-07",
"first_cert_date": "2023-09-07",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2023-09-07 ~ 2026-09-06"
}
],
"company_name": "(주)에이치엔바이오",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 100000000,
"cost_of_sales": 4799773000,
"current_assets": 3018836000,
"current_liabilities": 2832166000,
"gross_profit": 943513000,
"net_income": 226956000,
"net_income_bs": 209263000,
"non_current_assets": 40176000,
"non_current_liabilities": 0,
"non_operating_expenses": 69900000,
"non_operating_income": 21355000,
"operating_profit": 275501000,
"revenue": 5743286000,
"sga_expenses": 668012000,
"total_assets": 3059012000,
"total_equity": 226846000,
"total_liabilities": 2832166000
},
"2023": {
"capital_stock": 300000000,
"cost_of_sales": 10017950000,
"current_assets": 4346912000,
"current_liabilities": 3194534000,
"gross_profit": 1986313000,
"net_income": 536381000,
"net_income_bs": 506513000,
"non_current_assets": 110981000,
"non_current_liabilities": 330000000,
"non_operating_expenses": 138613000,
"non_operating_income": 94325000,
"operating_profit": 580669000,
"revenue": 12004263000,
"sga_expenses": 1405644000,
"total_assets": 4457893000,
"total_equity": 933359000,
"total_liabilities": 3524534000
},
"2024": {
"capital_stock": 300000000,
"cost_of_sales": 18898715000,
"current_assets": 8598452000,
"current_liabilities": 6609239000,
"gross_profit": 3246158000,
"net_income": 1121081000,
"net_income_bs": 1048070000,
"non_current_assets": 199216000,
"non_current_liabilities": 297000000,
"non_operating_expenses": 209788000,
"non_operating_income": 182814000,
"operating_profit": 1148055000,
"revenue": 22144873000,
"sga_expenses": 2098103000,
"total_assets": 8797668000,
"total_equity": 1891429000,
"total_liabilities": 6906239000
}
},
"industry": "상품 종합 중개업",
"investment": [],
"main_products": "건강기능식품",
"phone": "02-3471-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |